Commonwealth of Pennsylvania Public School Employees Retirement System’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,702
Closed -$194K 1584
2023
Q3
$194K Sell
17,702
-10,192
-37% -$130K ﹤0.01% 1603
2023
Q2
$369K Buy
27,894
+1,903
+7% +$27.1K ﹤0.01% 1630
2023
Q1
$354K Sell
25,991
-280
-1% -$5.02K ﹤0.01% 1672
2022
Q4
$513K Buy
26,271
+3,906
+17% +$76.3K ﹤0.01% 1541
2022
Q3
$426K Buy
22,365
+3,898
+21% +$89.8K ﹤0.01% 1682
2022
Q2
$380K Buy
18,467
+1,134
+7% +$26.9K ﹤0.01% 1723
2022
Q1
$558K Buy
+17,333
New +$630K 0.01% 1521

Other funds holding ITOS

Commonwealth of Pennsylvania Public School Employees Retirement System's ITOS Position: Q4 2023 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 17,702 shares — an estimated $194K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $558K in Q1 2022. 138 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 17,702 iTeos Therapeutics shares in Q4 2023, an estimated $194K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's iTeos Therapeutics position peaked at $558K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q4 2023, filed 9 Feb 2024.